That would be inaccurate. Recording of revenues for sales can be done in various ways. A purchase order in February might not be recorded until the following Q. The numerous product testing out there now can result in various agreements depending on the size of the entity. Credit lines, 10%, 20 net, etc. All will be stepped up after the 6 month est. buildout for "CyberFuels" specific existing products and formulas area of the Terminal.
Seems pretty obvious ECSL "guarterly" disclosure isn't for the 3 months ended March 31. ECSL doesn't report this way. Nor does report say it is for the "3 months ended" March 31. Sez for "period ended" as always.
The "beginning" numbers match all those from June 30, 2022 annual report vs the ending numbers from the December report.
Just another continuing deceptive practice by ECSL mgmt.
No inventory at March 31 and patent assignment info is always interesting.
Market Data 
Markets 
AI
